2016. BSG Conference – A Multinational Study to Determine Indicators of Suboptimal Therapy Among Ulcerative Colitis Patients Treated with Tumor Necrosis Factor Antagonists

Lindsay JO, Gisbert JP, Mody R, Peyrin-Biroulet L, Armuzzi A, Bokemeyer B, Nguyen GC, Siebenaler J, Åkerborg Ö, Smyth M. A Multinational Study to Determine Indicators of Suboptimal Therapy Among Ulcerative Colitis Patients Treated with Tumor Necrosis Factor Antagonists. Gut 2016;65(Suppl 1):A253. Presented at: BSG 2016 Conference; June 20-23, 2016; Liverpool, UK.